Catalyst Wire Dossier Catalyst Wire Dossier

Embrace Hydrogel Embolic System (HES)

Hydrogel embolic system · Instylla, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Embrace Hydrogel Embolic System (HES), covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds [NA]

See pricing